Research has identified dysfunction in the cortico-striato-thalamo-cortical (CSTC) circuit as a central mechanism in OCD. This neural loop, which normally helps filter and prioritize thoughts, becomes hyperactive in OCD, causing the brain to assign extreme importance to intrusive thoughts that most people would dismiss. Neuroimaging studies consistently show increased activity in the orbitofrontal cortex and caudate nucleus in OCD patients.
Serotonin dysregulation plays a significant role, which is why selective serotonin reuptake inhibitors (SSRIs) have been a first-line treatment. However, approximately 40-60% of OCD patients do not respond adequately to SSRIs alone, highlighting the involvement of additional neurotransmitter systems including glutamate, the brain's primary excitatory chemical messenger.
Glutamate signaling abnormalities in the CSTC circuit create a state of neural hyperexcitability, reinforcing the obsessive-compulsive cycle. This understanding has opened new treatment pathways, including ketamine therapy, which modulates glutamate receptors to help restore balanced neural signaling.
